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Bones of the cranial vault are formed by the differentiation of mesenchymal cells into
osteoblasts on a surface that surrounds the brain, eventually forming mineralized bone. Sig-
naling pathways causative for cell differentiation include the actions of extracellular proteins
driven by information from genes. We assume that the interaction of cells and extracellular
molecules, which are associated with cell differentiation, can be modeled using Turing’s
reaction–diffusion model, a mathematical model for pattern formation controlled by two
interacting molecules (activator and inhibitor). In this study, we hypothesize that regions of
high concentration of an activator develop into primary centers of ossification, the earliest
sites of cranial vault bone. In addition to theTuring model, we use another diffusion equation
to model a morphogen (potentially the same as the morphogen associated with formation
of ossification centers) associated with bone growth. These mathematical models were
solved using the finite volume method. The computational domain and model parameters
are determined using a large collection of experimental data showing skull bone formation
in mouse at different embryonic days in mice carrying disease causing mutations and their
unaffected littermates. The results show that the relative locations of the five ossification
centers that form in our model occur at the same position as those identified in experi-
mental data. As bone grows from these ossification centers, sutures form between the
bones.
Keywords: computational morphogenesis, finite volume method, skull growth, developmental biology,
skull sutures
1. INTRODUCTION
Bones of the mammalian cranial vault are formed by the process
of intramembranous ossification where condensations of mul-
tipotent mesenchymal cells differentiate directly into function-
ing osteoblasts to form bone (Tubbs et al., 2012; Percival and
Richtsmeier, 2013). Figure 1 shows the estimated length and time
scales associated with various processes of skull development in the
mouse. The study of the formation of cranial vault bones is critical
because it may help uncover fundamental mechanisms associated
with birth defects such as craniosynostosis (involving premature
closure of cranial vault sutures and skull dysmorphology) as well
as answer basic questions in developmental biology and evolution.
Initially, undifferentiated mesenchymal cells migrate to future
sites of bone formation situated on the brain and its meningeal lay-
ers (pia, arachnoid, dura mater). Over time, the proliferation and
differentiation are regulated by growth factor signaling pathways
and their downstream transcription factors in order for these cells
to become committed to an array of different fates. In some cells,
the intracellular signaling pathways cause differentiation of mes-
enchymal cells into osteoblasts, the cells that build bone (Marie
et al., 2002; Gordeladze et al., 2010; Tubbs et al., 2012). Differenti-
ation of condensed groups of osteoblasts results in the formation
of ossification centers that form in tissue membranes surrounding
the brain. Next, osteoblasts begin to secrete a bone matrix, osteoid,
which is then mineralized, eventually forming a bone of the cranial
vault. For the mouse, the process of cell migration begins around
embryonic day 9 (E9) and skull bone growth continues postnatally,
involving length scales ranging from the nanometer to millimeter
as schematically shown in Figure 1.
In order to understand the fundamental mechanisms of skull
growth, both experimental and computational methods have been
employed. Many studies have experimentally studied the roles of
various proteins in cranial bone formation (Holleville et al., 2003;
Wan and Cao, 2005) and growth of cranial bones (Martínez-
Abadías et al., 2013; Motch Perrine et al., 2014; Percival and
Richtsmeier, 2013) and compared the craniofacial bone growth
patterns of normal mice and those carrying mutations that in
humans cause disease. Figure 2 shows that cranial vault bone
elements (frontal, parietal, and interparietal bones) appear from
embryonic day 14.5 (E14.5) and continue to grow through post-
natal day 0 (P0) and beyond. It also shows that the frontal bone
forms first and the interparietal bone forms later, forming sutures
between individual bones while they grow. Experimental stud-
ies are extremely valuable but can be costly and only so many
variations can be explored. Therefore, it is valuable to also exam-
ine the possibility of using computational methods to understand
fundamental mechanisms of morphogenesis.
Several computational studies have been conducted to model
the process of skull bone formation. A mathematical model
for reaction–diffusion controlled by two interacting chemical
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FIGURE 1 | Components associated with generalized mouse cranial vault bone development ranging from molecules to tissue according to time and
length scale. Data are generated from observations of C57Bl6 mice.
molecules, proposed by Turing (1952), has been employed in the
study of biological pattern formation and development of biolog-
ical systems. Kondo and Shirota (2009) analyzed the mechanism
of skin pattern formation of animals using the Turing model
and (Marcon and Sharpe, 2012) adopted the model to explain
various biological development processes. Garzón-Alvarado et al.
(2013) used the model to establish a computational framework for
investigating bone formation in human cranial vault. The model,
commonly referred to as the reaction–diffusion model, shows that
through the regulatory loop of interacting molecules the concen-
tration of the molecules forms an inhomogeneous special pattern
in space. In this study, we adopt an approach similar to that of
Garzón-Alvarado et al. (2013), to study growth of the skull in a
mouse model of human disease and then propose an extension of
the framework.
As depicted on Figure 1, we subdivide the process into two
stages: (1) initiation (differentiation) of primary centers of ossi-
fication; and (2) bone growth. In the first stage, we focus on
differentiation of osteoblast lineage cells (OLCs),which leads to the
initial primary centers of ossification of the flat bones of the cranial
vault. We assume that the interaction of extracellular molecules,
which are associated with the differentiation process of OLCs along
an osteogenic path, can be modeled using the reaction–diffusion
model. Reaction–diffusion models can be further subdivided into
activator–inhibitor and activator–substrate models according to
how molecules interact with each other (Gierer and Meinhardt,
1972). The primary difference between the two models is the
way one molecule inhibits the other molecule. In the activator–
inhibitor model, one molecule (activator) enhances the other
molecule (inhibitor) but the enhancement of inhibitor inhibits
the action of activator so that the molecules are in phase. On the
other hand, in the activator–substrate model, one molecule (acti-
vator) consumes the other molecule (substrate) to be enhanced
and eventually is restricted by depletion of the other molecule
(substrate) so that the molecules are not in phase. More details
about these models can be seen in a work of Koch and Meinhardt
(1994). Since many details remain to be discovered in order to fully
understand the key molecular players in proliferation and differ-
entiation of OLCs as they form intramembranous bones of the
cranial vault, it is currently not known whether the activator–
inhibitor or the activator–substrate approach more accurately
models intramembranous bone formation. Since the activator–
inhibitor model more closely models what has been observed
experimentally and because the regulatory relation in the model
is simpler, unlike Garzón-Alvarado et al. (2013), we employ the
activator–inhibitor model.
In the second stage, we deal with the rapid proliferation of bone
cells from the primary condensations and their outward migration
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FIGURE 2 | Formation of the mouse skull. (A–C) Histological images of
developing mouse embryos showing formation of bone (magenta stained by
alizarin red) and cartilage (stained by alcian blue) of the embryonic skull.
(A) lateral view of embryonic mouse head at embryonic day 14.5 (E14.5)
showing site of initial ossification of the frontal bone of the cranial vault (red
arrow) and skull cartilage; (B) at E15.5, the forming frontal and parietal bones
are clearly visible and the ossification of the interparietal bone is beginning
(arrow); (C) By E17.5, the interparietal is well formed and other bones of the
skull are clearly visible. (D) 3D reconstruction of micro computed tomography
image of the mouse skull at birth (P0) colored to indicate the placement and
level of maturity of all skull bones. (E) Adult mouse skull colored to show
relative position of skull bones.
(stage 1) to form bones of the cranial vault, particularly the frontal
and parietal bones. Work from other laboratories collectively sug-
gest a pattern of presumptive bone cells expanding outward from
mesenchymal condensations, predominantly towards the apex of
the head (Iseki et al., 1997; Rice et al., 2000; Ting et al., 2009).
Under normal regulatory conditions, these expanding condensa-
tions represent the primary region of osteoblast differentiation,
the source of differentiating cells, and locus of osteogenesis and
bone growth. They also define the earliest shapes of developing
bones. We modeled the action of the morphogen stimulating bone
growth from these osteoblasts.
In this paper, we present a combined experimental and compu-
tational study of cranial bone growth. In Section 2, we present the
computational framework for determining the location of primary
ossification centers and simulating growth of individual bones of
the cranial vault. Our computational predictions are guided and
compared to a large archive of experimental data. Micro com-
puted tomographic (µCT ) images of mouse heads of various
embryonic ages were used for making a computational domain
and testing and tuning the mathematical model by comparison
between experimental and computational results. Section 3 gives
results of the simulation and discussions about them are made in
Section 4. Finally, in Section 5, we conclude and summarize our
findings and provide suggestions for future work.
2. MATERIALS AND METHODS
2.1. MATHEMATICAL MODEL
2.1.1. Regulation of osteoblast differentiation
Osteoblasts differentiate from mesenchymal progenitors, going
through distinct developmental stages,which are regulated by vari-
ous developmental signals. Although the role of key developmental
signals is well defined, most of this knowledge comes from studies
of endochondral development of long bones and even there, lit-
tle is known about how the signals execute the osteoblast-specific
differentiation program (Long, 2011).
This study is based on the hypothesis that differentiation of
mesenchymal cells takes place by chemical reactions triggered by
the interaction of extracellular molecules (both local and systemic
regulatory signals), with cell surface ligands, although it is impor-
tant to point out that the specific proteins in the mouse system are
not clearly determined. Thus, we quickly arrive at one challenge of
this approach: determining quantitative values of the parameters
that represent specific proteins. We acknowledge that parameters
are the cause of great speculation throughout this study and main-
tain that developing this model as part of a collaborative project
that seeks to precisely define the role of the critical molecular
participants will improve our model over time. Conversely, it is
clearly a challenge to obtain and measure these parameters exper-
imentally, and we propose that computational studies presented
here will help elucidate possible bounds of parameters and guide
the design of future experiments to determine their values with
increased certainty. To mitigate the speculative nature of parame-
terization, we conduct a stability analysis that helps to bound some
values and parametric studies to estimate the effects of some of
the parameters.
Figure 3 is a schematic diagram showing the process of differ-
entiation of mesenchymal cells to osteoblasts and the regulatory
relationship between extracellular molecules, which influence cell
differentiation. In our model, mesenchymal cells surrounding the
brain express diffusible extracellular molecules, which play a key
role in cell differentiation and the molecules are assumed to follow
behaviors that can be described using the activator–inhibitor
www.frontiersin.org March 2015 | Volume 3 | Article 24 | 3
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FIGURE 3 | Schematic diagram of extracellular and cellular process
associated with differentiation of mesenchymal cells to osteoblast
cells. Undifferentiated mesenchymal cells surrounding the brain
express diffusible extracellular molecules, which play a key role in cell
differentiation ( and ). One of the molecules (activator) activates
signaling pathways to initiate cell differentiation of mesenchymal cells
into osteoblasts (). In an extracellular process, the activator
simultaneously enhances itself () and the other key molecule
(inhibitor) (), while the inhibitor inhibits the activator (). These two
proteins eventually establish a regulatory loop and diffuse in space with
different speed () to form an inhomogeneous spatial pattern of
concentration.
model (Figure 3, and ). The activator initiates chemical reac-
tions that activate signaling pathways to initiate differentiation of
mesenchymal cells into osteoblasts (Figure 3,). In an extracellu-
lar process, the activator simultaneously enhances itself (Figure 3,
) and the inhibitor (Figure 3,), while the inhibitor inhibits the
activator (Figure 3, ). These two proteins eventually establish a
regulatory loop and the diffusion of products of the inhibitor and
activator (Figure 3, ) form an inhomogeneous spatial pattern
of concentration that results in molecules condensing at specific
locations in a domain. The features of an activator–inhibitor sys-
tem can be mathematically modeled using a reaction–diffusion
model, which is given by:
∂Ca
∂t
= σa − µaCa + ρa C
2
a
Ch
+ Da∇2Ca (1a)
∂Ch
∂t︸︷︷︸

= σh︸︷︷︸

−µhCh︸ ︷︷ ︸

+ ρhC2a︸ ︷︷ ︸

+Dh∇2Ch︸ ︷︷ ︸

(1b)
where, Ca and Ch represent the concentration of activator and
inhibitor, respectively. σ a and σ h are the constants quantifying the
production of activator and inhibitor from mesenchymal cells.
The parameters µa and µh quantify degradation or depletion of
the proteins. The parameters ρa and ρh are constants associated
with the non-linear interaction between activator and inhibitor.
The interaction term shows that the activator enhances itself and
the inhibitor [Ca2 in numerator in equations (1a) and (1b)] but is
constrained by the inhibitor [Ch in denominator in equation (1a)].
Da and Dh represent the diffusion rate of each molecule and52 is
the Laplace operator
(
i.e.,
∑3
i=1 ∂
2
∂xi 2
)
describing the spatial dif-
fusion of molecules. So equations (1a) and (1b) show that the time
rate of change of concentration of each molecule [equations (1a)
and (1b)-] is determined by its production from mesenchymal
cells [equations (1a) and (1b)-], degradation [equations (1a)
and (1b)-], interaction between the two molecules [equations
(1a) and (1b)-] and diffusion into space [equations (1a) and
(1b)-].
In this model, parameters should satisfy a certain constraint in
order to make an inhomogeneous spatial pattern from a very small
perturbation on a homogeneous initial condition. If diffusion of
a molecule is fast relative to the reaction between activator and
inhibitor, a small perturbation cannot be amplified but the mol-
ecules will reach another homogeneous condition. In the future,
actual values of parameters might be defined by way of labora-
tory experiments but experiments that quantify these types of
parameters are currently limited. Therefore, parameters should be
estimated with careful consideration of the biologically reason-
able range. Additionally, Koch and Meinhardt (1994) suggested
constraints that the parameters should satisfy for pattern forma-
tion using a linear stability analysis. Homogeneous, steady state
initial concentration of each molecule can be achieved mathemat-
ically by setting time rate of change and spatial diffusion terms in
equations (1a) and (1b) be to zero:
Ca0 = µhρa
µaρh
+ σa
µa
, Ch0 = ρh
µh
C2a0 (2)
where Ca0 and Ch0 signify the concentration of activator and
inhibitor, respectively, at steady state. By adding a small pertur-
bation to the homogeneous steady condition, the concentration
of two molecules can be represented as equations (3a) and (3b)
where,
Ca = Ca0 + δCa , Ch = Ch0 + δCh (3a)
δCa = δCa0eωt cos(2pikx), δCh = δCh0eωt cos(2pikx) (3b)
In equation (3b) perturbation δCa and δCh are assumed to
change in time and space. The value ω can be a complex number
and the imaginary part of it represents a frequency at which the
perturbation changes in time. The change in space is characterized
by wave number k, which is associated with ω. When the real part
of the frequencyω is positive, the perturbation increases with time
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so that concentrations of molecules can form an inhomogeneous
spatial pattern. By substituting equations (2), (3a), and (3b) into
equations (1a) and (1b) and conducting a linear stability analysis,
a condition, which parameters should satisfy for pattern formation
(i.e., for making the real part of ω to be positive) can be obtained
as below:
2µhρa
µhρa + σaρh − 1 ≤
µh
µa
<
Dh
Da
2(√
2µhρa
µhρa + σaρh − 1
)
(4)
Details can be found in Koch and Meinhardt (1994). In this
study, we used a set of parameters, which meet the condition of
equation (4) as listed in Table 1. Using values in Table 1 with equa-
tion (4) yields: 0.667< 2.0< 8.468. The effects of various model
parameters on the results can be seen in Supplementary Material.
Similar to Garzón-Alvarado et al. (2013), our model is based
on the hypothesis that differentiation of mesenchymal cells into
osteoblasts is triggered by an activator. Here, we acknowledge that
there are several biological stages prior to the final differentiation
of OLCs into osteoblasts (Figure 4), so our model focuses
on cellular mechanisms occurring after the concentration of
Table 1 | Model parameters in reaction–diffusion model of activator
and inhibitor.
Parameters Value Units
Activator production σ a 1.0×10−5 ng/(mm3× s)
Inhibitor production σ h 1.0×10−5 ng/(mm3× s)
Activator depletion µa 5.0×10−5 /s
Inhibitor depletion µh 1.0×10−4 /s
Activator coupling ρa 5.0×10−5 /s
Inhibitor coupling ρh 1.0×10−4 mm3/(ng× s)
Activator diffusion Da 2.5×10−6 mm2/s
Inhibitor diffusion Dh 2.5×10−4 mm2/s
OLCs has formed and the cells have started along an osteoblast
differentiation trajectory. These cells are more likely to form
osteoblasts where concentration of activator is high. In addition
to concentration of activator, spatial positions of cells are also
found to affect the rate of cell differentiation. Tubbs et al. (2012)
shows that cells on the inferior surface (that will form bones of the
skull base) differentiate faster than cells on the superior surface
(cranial vault bones). With these impacting factors on cell differ-
entiation the rate of generation of osteoblast can be modeled by
the equations (5a) and (5b).
∂Co
∂t︸︷︷︸

= η Ca
n
Can +CaT n︸ ︷︷ ︸

Ta
n
Ta
n +tn︸ ︷︷ ︸

f (xrel)︸ ︷︷ ︸

(5a)
f (xrel) = H (xref − xrel) =
{
1 xrel ≤ xref
0 otherwise
(5b)
In the equations, Co represents the concentration of osteoblast
and Ca indicates the concentration of activator as before. CaT
represents the threshold concentration of activator that allows
mesenchymal cells to differentiate, which means only cells in the
region where the concentration of activator exceeds the threshold
value can differentiate into osteoblasts.Ta represents the time limit
of action of the activator, in other words after this time is reached
the action of the activator decreases. The value η is a constant
quantifying the amount of osteoblast generated by action of acti-
vator. The value n is a constant characterizing how sharply the rate
of cell differentiation increases after the concentration of activator
reaches the threshold value. The function f(xrel) is a term about
spatial effect on cell differentiation and limits differentiation to
those cells below the reference position (xref). This function can
be represented by Heaviside function as shown in equation (5b).
The relative distance from inferior surface of the domain (xrel) and
reference position (xref) are shown in Figure 5. So equations (5a)
FIGURE 4 | Stages of osteoblast lineage cell (OLC) differentiation.
Mesenchymal progenitors give rise to osteoblasts and chondrocytes and
are usually marked by SOX9. If SOX9+ cells do not differentiate into
chondrocytes, they progress along an osteogenic path and as they mature,
they are marked progressively by the expression of RUNX2, followed by
OSX. Additional evidence suggests that SOX9+ cells can switch fates
under certain conditions (indicated by dotted lines) [adapted from Long
(2011)].
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FIGURE 5 | Lateral view of a 3D domain. The relative distance from
inferior surface of the domain (xrel) and reference position (xref) are indicated.
Our model limits differentiation to those cells below the reference position.
Table 2 | Model parameters in cell differentiation model.
Parameters Value Units
Differentiation constant η 1.0×10−5 ng/(mm3× s)
Activator threshold CaT 6.0 ng/mm3
Activator time limit Ta 4.0×102 hr
Control constant n 8.0
Reference position xref 1.85 mm
Maximum position xtop 2.49 mm
and (5b) show that the rate of cell differentiation [equation (5a)-
] is determined by concentration of activator [equation (5a)-
], elapsed time in the differentiation process [equation (5a)-]
and spatial position [equation (5a)-]. Numerical values of the
model parameters about cell differentiation used in this study are
arranged in Table 2.
2.1.2. Bone growth
After the formation of primary ossification centers, essentially con-
densations of osteoblasts differentiated from mesenchymal cells,
bone grows from these centers by a combination of the produc-
tion of osteoid and its mineralization by osteoblasts and continued
differentiation of rapidly proliferating mesenchymal cells that
migrate outwards from the condensation (Iseki et al., 1997; Rice
et al., 2000; Yoshida et al., 2008; Ting et al., 2009). The process can
be shown schematically in Figure 6. Osteoblasts in the ossification
centers begin to secret various morphogens. Some of these mor-
phogens (e.g., Dlx5) are produced from osteoblasts and diffuse
into the neighboring space allowing adjacent mesenchymal cells
to differentiate into osteoblasts. Experimental data reveal in mice
that five primary ossification centers, one each for the bones of
the cranial vault (right and left frontal, right and left parietal and
interparietal bones) that appear first on the more rostral surface of
the embryonic mouse brain as shown in Figure 2. The squamous
portion of the occipital bone develops later. In normal condi-
tions, the bones of the skull vault are separated by sutures, fibrous
joints that accommodate the expanding brain and allow the skull
to undergo reshaping during birth (Ting et al., 2009). Although
the mechanisms of suture formation are only partly known, most
research favors molecular mechanisms that balance the prolif-
eration and differentiation of osteogenic cells in the developing
sutures (Lee et al., 1999; Yousfi et al., 2001, 2002; Chen et al., 2003;
Bialek et al., 2004) and/or that establish tissue boundaries (Merrill
et al., 2006; Ting et al., 2009) in suture formation and premature
closure of sutures. Similar to Garzón-Alvarado et al. (2013) in
this study, suture formation between bone elements is modeled
by assuming that differentiation of mesenchymal cells adjacent
to bone is restricted by the morphogen secreted from the adja-
cent bone elements, although we realize that the signaling could
come from, or be transmitted through dura mater surrounding
the developing brain (Opperman, 2000; Richtsmeier and Flaherty,
2013). The differentiation process in the bone growth stage is
modeled by following equation in this study.
∂Co−i
∂t︸ ︷︷ ︸

= λ CoS−i
n
Co−i n +CoS−i n︸ ︷︷ ︸

Cm−i n
Cm−i n +CmT−i n︸ ︷︷ ︸

×
5∏
j=1;j¬i
Cml−j n
Cm−j n +Cml−j n︸ ︷︷ ︸

(6)
In this equation, Co indicates the concentration of osteoblast
and subscription i indicates any quantities of i-th bone where i
can represent the number of different regions of skull bone (in
our case, 5 regions: right and left frontal, right and left parietal and
interparietal bone). Cos is saturation concentration of osteoblast
that sets the upper limit of generation of osteoblast. Cm repre-
sents the concentration of the morphogen, which is secreted from
osteoblasts and allows differentiation of adjacent mesenchymal
cells.CmT is the threshold value of the morphogen that triggers dif-
ferentiation of mesenchymal cells. Cml in equation (6) represents
the limitation concentration of the morphogen, in which cell dif-
ferentiation of i-th bone is restricted when it senses morphogen
above this value secreted from j-th bone (i 6= j). λ is a constant
quantifying the amount of osteoblast differentiated by action of
the morphogen. n is a constant characterizing how sharply the
rate of cell differentiation increases after the concentration of the
morphogen reaches the threshold value, or decreases after concen-
tration of osteoblast and morphogen from other regions of bone
elements reach a saturation and limitation value, respectively. So
equation (6) says that the rate of cell differentiation in one bony
element [equation (6)-] is determined by saturation control by
itself [equation (6)-], action of the morphogen allowing cell dif-
ferentiation [equation (6)-], and restriction by the morphogen
from other bony elements [equation (6)-].
In our model, the production and diffusion of the morphogen
associated with bone growth are modeled by another diffusion
equation:
∂Cm−i
∂t︸ ︷︷ ︸

= α Co−i︸︷︷︸

CmS−i n
Cm−i n +CmS−i n︸ ︷︷ ︸

+Dm−i∇2Cm−i︸ ︷︷ ︸

(7)
In this equation, Cm represents the concentration of the mor-
phogen. Co indicates the concentration of osteoblasts from which
the morphogen is expressed. CmS is the saturation concentration
of the morphogen, in which, production of the morphogen is
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FIGURE 6 | Schematic diagram of bone growth from primary
ossification centers. Osteoblasts in the ossification centers begin
to secret a morphogen, which diffuses into the neighboring space
and allows adjacent mesenchymal cells to differentiate into
osteoblasts. Suture formation between bone elements is modeled
by assuming that differentiation of mesenchymal cells adjacent to
bone is restricted by the morphogen secreted from the adjacent
bone elements.
Table 3 | Model parameters in bone growth model.
Parameters Value Units
Morphogen constant α 5.0×10−5 /s
Morphogen saturation CmS 2.0 ng/mm3
Morphogen diffusion Dm 1.2×10−7 mm2/s
Growth constant λ 1.0×10−1 ng/(mm3× s)
Osteoblast saturation CoS 1.0 ng/mm3
Morphogen threshold CmT 2.0 ng/mm3
Morphogen limitation Cml 1.0×10−3 ng/mm3
restricted after this value. Dm represents diffusion rate of the
morphogen and52 is the Laplace operator describing spatial dif-
fusion of the morphogen. α is a constant quantifying the amount
of the morphogen expressed by osteoblasts. n is a constant char-
acterizing how sharply the expression of the morphogen decreases
after the concentration of the morphogen reaches the saturation
value. So equation (6) shows that the time rate of change of the
morphogen concentration [equation (7)-] is affected by con-
centration of already differentiated osteoblasts [equation (7)-],
which secrete the morphogen, restriction when it reaches satu-
ration [equation (7)-] and diffusion into space occupied by
undifferentiated mesenchymal cells [equation (7)-]. The model
parameters used with equations (6) and (7) are listed in Table 3.
2.2. NUMERICAL IMPLEMENTATION
The finite volume method using the open source code OpenFOAM
2.2.2 was applied to solve the reaction–diffusion model of activator
and inhibitor, cell differentiation model, and bone growth model
[equations (1a), (1b), (5a), (5b), (6), and (7)].
2.2.1. Computational domain
In our previous study, the reaction–diffusion model of activator
and inhibitor (BMP2 and Noggin in the paper) was solved in a
one-dimensional and two-dimensional domain (Lee et al., 2014).
In this study, we used three-dimensional reconstructions of micro
CT images of mouse heads at embryonic day 17.5 (E17.5) to con-
duct a computational simulation on a more realistic domain. At
E17.5, some parts of mouse skull are already formed as shown
in Figure 7. We considered only bones of the cranial vault and
simplified them to make a surface on which reaction–diffusion
of extracellular molecules takes place. Then we made a shell-
shaped domain around the surface and generated a mesh using
commercial software ANSYS ICEM. The length of the vault is
approximately 7 mm and the thickness of the shell is about 0.3 mm.
In total, 84,200 elements are used for the calculation. In future
applications, we will move these simulations to surfaces of earlier
embryonic ages before bone is formed to more realistically model
the domain prior to the initiation of cranial vault bone formation.
2.2.2. Initial condition
From a computational point of view, initial conditions are a signifi-
cant aspect to consider in a simulation. The model in this study also
depends on initial concentration of activator and inhibitor mol-
ecules. Different initial concentrations of activator and inhibitor
result in significant changes in the final bone growth patterns.
The effect of various initial conditions can be seen in Supplemen-
tary Material. Experimental research reveals that mesenchymal
condensations that will form the primary centers of ossifica-
tion initiate at the supra orbital region just above the globe of
the eye and develop into right and left frontal bones (Tubbs
et al., 2012). Based on these observations, we initiated a small
perturbation of activator (0.5% of steady state condition) only
at two points corresponding to the location of the right and
left frontal bones on the domain. Consequently, the entire sur-
rounding domain has steady state concentration of activator and
inhibitor [Ca0= 1.20 ng/mm3, Ch0= 1.44 ng/mm3 in equation
(3a)] except the two points as shown in Figure 8. Zero-gradient of
concentration of molecules was applied as boundary condition at
domain boundaries, which means there is no flux of molecules by
diffusion across the boundaries.
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FIGURE 7 | Procedure for constructing a computational domain.
(A) An isosurface of the cranial vault bones from a three-dimensional
reconstruction of micro CT images acquired from a mouse at E17.5 was
used for making the domain and generating a mesh. Rostral end (nose) is
toward the top while the caudal end of the skull is at bottom. (B) Only
parts of cranial vault are considered. (C) Surface surrounding the cranial
vault is made. (D) Shell-shaped domain around the surface and mesh are
generated.
FIGURE 8 | Initial condition. A small perturbation of activator on two
points on the frontal side of domain was given as an initial condition.
Elsewhere the domain has homogeneous concentration of activator and
inhibitor. This condition is based on the biological observation showing that
mesenchymal condensations initiate at the supra orbital region just above
the globe of the eye and develop into right and left frontal bones.
3. RESULTS
3.1. PRIMARY OSSIFICATION CENTERS
The reaction–diffusion model [equations (1a) and (1b)] and the
cell differentiation model [equations (5a) and (5b)] were solved
using the finite volume method and changes in concentrations
of activator, inhibitor, and osteoblasts in the domain were exam-
ined over time. We assume mesenchymal cells are present near
E0. This assumption is not the case in real development because
there is neither brain formed nor mesenchymal cells surrounding
the brain, but helps to establish a modeling process. Simulation
using a brain shape at earlier time is planned in a subsequent
research.
Figure 9 shows the concentrations of activator and inhibitor
at time 0 and after E15.4. At time E0 activator and inhibitor are
FIGURE 9 | Concentrations of activator and inhibitor at embryonic day
0 and 15.4 from simulation result. Small perturbation of activator at initial
time increases through regulatory reaction between activator and inhibitor,
and finally makes a specific pattern of concentration of activator and
inhibitor after 15.4 days. Activator and inhibitor are in phase. Six regions of
high concentration of the molecules appear, two on the front, two on the
side, one on the rear, and one on the top of the domain.
distributed uniformly through the domain with only 0.5% of dis-
turbances of activator on the two points at frontal side. These small
perturbations at time E0 increase over time by regulatory reaction
between activator and inhibitor to make a specific pattern of con-
centration in the domain so that six highly concentrated regions
appear as shown in result at E15.4. Concentrations of activator
and inhibitor are in phase and reveal the key feature of activator–
inhibitor models: the activator is enhanced by itself and activates
the inhibitor, but the inhibitor acts only to inhibit the activator.
Based on our hypothesis that differentiation of mesenchymal cells
to osteoblasts will occur local to points of elevated concentration of
activator, our cell differentiation model [equations (5a) and (5b)]
predicts five primary centers of ossification as shown in Figure 10.
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Figure 10 shows the concentrations of osteoblasts at E0
and E15.4. We consider the regions where the concentration of
osteoblast exceeds a threshold value (1.0 ng/mm3) to develop into
a bony element via the formation of primary ossification cen-
ters and these regions are shown as opaque while other regions are
translucent in Figure 10. Compared to the distribution of the acti-
vator (Figure 9), the primary ossification centers appear where the
concentration of the activator is high except the top of the domain.
The top of the domain has high concentration of the activator but
due to spatial effect on cell differentiation, which we assume in
the model [governed by equations (5a) and (5b)] ossification does
not initiate in this region. Biologically, this may be an important
observation as this is the location where the anterior fontanelle
(soft spot) forms in developing heads. Five primary ossification
centers form and are located on the right and left side of the ante-
rior region, on the right and left side of the middle region, and in
FIGURE 10 | Concentration of osteoblast at embryonic day 0 and 15.4
from simulation result. Osteoblasts are differentiated in the regions
where concentration of activator is high. And these regions of osteoblasts
can develop into mineralized bone that is primary centers of ossification.
Osteoblasts are not differentiated on the top of the domain although
concentration of activator is high there, due to the spatial effect on cell
differentiation in our model. Five primary centers of ossification and this
agree well with experimental observation showing two frontal, two parietal,
and a single interparietal bones.
the center of the rear side of the domain, respectively. These com-
putationally generated centers of ossification correspond with the
biological location of the right and left frontal bones, right and left
parietal bones, and interparietal bone, respectively.
3.2. BONE GROWTH
The bone growth model [equations (6) and (7)] was solved using
the results of primary ossification centers as an initial condition
and the change of concentration of differentiated osteoblast was
examined. Figure 11 shows only regions where concentration of
osteoblasts exceeds the threshold value (1.0 ng/mm3), which can
develop into bone eventually. It shows the regions of high concen-
tration of osteoblasts expand from the primary ossification centers
from E15.4 to E22.9. The region of condensed osteoblasts on the
posterior end of the domain grows slow compared to the other
four regions because this primary ossification center is the last to
form and is smaller in size. Spaces between the ossifying regions
become reduced as the bones grow but they do not meet each
other because of the repulsive effect that occurs between bones in
the model. This is an important aspect of our model, which may
model suture formation.
4. DISCUSSION
The number and locations of ossification centers found in the
simulation results (Figure 10) agree well with experimental data
showing five ossification centers representing the two frontal, the
two parietal, and the single interparietal bones of the cranial vault
(Figures 2 and 7B). Based on the fact that these results were com-
puted by not specifying any locations, which would eventually
become ossification centers, but by only solving the diffusion–
reaction model with proper initial perturbations and model para-
meters, the computational framework using Turing’s model can be
seen as one reasonable approach for exploring processes required
for the formation of primary ossification centers and for cranial
vault growth.
The results of simulation of bone growth (Figure 11) show that
the region of osteoblasts expands from the ossification centers.
Our bone growth model explains this process as differentiation of
adjacent undifferentiated mesenchymal cells near primary centers
of ossification into osteoblasts by the action of a morphogen that is
expressed from pre-existing osteoblasts and diffused in space with
FIGURE 11 | Change of region of high concentration of osteoblast over
time. The regions originally marked by the differentiation of osteoblasts
expand from the primary centers of ossification over time. Because these
osteoblasts differentiate into osteocytes and eventually become trapped
within mineralized bone, it can be said to show pattern of bone growth. The
results agree well with experimental observation showing two frontal bones,
two parietal bones, and one interparietal bone. Sutures form between bones
as bones grow according to repulsive effect between bones in our model.
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time. This is in agreement with previous research that demon-
strates that the cells that add to the primary ossification centers
by differentiating into osteoblasts come from the condensations
rather than being recruited from other mesenchymal populations
surrounding the brain (Yoshida et al., 2008; Ting et al., 2009). Once
differentiated, osteoblasts function to produce osteoid along colla-
gen bundles and then mineralize that matrix eventually becoming
trapped within mineralized lacunae and differentiating into osteo-
cytes. Here,we have not modeled the entrapment of osteocytes into
a mineralized matrix, but the expansion of regions of high concen-
tration of osteoblasts is considered as bone growth. Results shown
at E20.4 (Figure 11) are representative of data at P0 because gesta-
tion period of mouse, although variable, is approximately 20 days.
The simulation result shows smaller volume of bones compared to
experimental data (Figure 2), which means a slower growth rate.
In addition, the relative size and shapes of the individual bones are
somewhat different from experimental observations. These differ-
ences can be overcome by subtle adjustment of model parameters
and, importantly, the adjustments may add to our knowledge of
the processes involved in the formation of ossification centers and
their growth. The effects of different model parameters on the
simulation are presented in Supplementary Material. Our hypoth-
esis that morphogens from one bone element inhibits the growth
of contiguous bones [equation (6)], may not be true, but can
be tested experimentally. That our results show suture formation
similar to what is observed experimentally suggests that suture
formation involves some kind of mechanism of repulsive factors
between bones, and this does not counter a hypothesis of boundary
formation between cellular compartments that serve as signaling
interfaces as suggested by others (Merrill et al., 2006; Ting et al.,
2009). Here, we suggest that the factors driving the formation of
sutures may include chemical substances or mechanical stimuli by
the growing brain or by opposing bones as the gaps between them
narrow. Since the processes that control normal suture develop-
ment and the mechanisms underlying abnormal premature suture
closure are not well understood, further research into the effects
of mechanical stress on bone growth is warranted.
Although the simulation captures many features of the devel-
opmental process, it has some limitations as well. Key molecules
play important roles in cell differentiation and their identity, as
well as the real values of these parameters remain to be deter-
mined. We expect this to be achieved in a follow-up study that
will elucidate the cellular-level changes that occur in cranial devel-
opment providing the basis for joining molecular cues and cell
behavior with 3D shape changes that occur during ontogeny. The
number of cells in initial ossification centers, rate of OLC differ-
entiation and proliferation, intracranial pressure gradients from
growth induced skull-soft tissue interaction, and rate of suture clo-
sure can be parameterized and modified in the model. The results
can be continually quantitatively compared to our extensive image
archive of developing cranial soft and hard tissues.
In this study, the computational domain is fixed in both size
and shape while in biological systems the surface on which bone
development occurs expands and changes shape as the underly-
ing brain grows. Indeed, the size and shape of the domain does
affect the number and location of ossification centers because dif-
fusion is strongly related with geometry of the domain. In the
future, we plan to let the shape of the computational domain
change (or “grow”) over time. This would offer a more realistic
model, but we realize that our diffusional parameters will need to
change over time as well. Some parts of our model are based on
the experimental observation rather than clear mechanical mech-
anisms of how sutures form, why ossification does not occur at
the top of the domain and how subtle, complicated shape of each
bone forms. We expect that mechanical stimuli such as pressure
and stress may affect these phenomena and they will be a focus of
a future study. In a forthcoming study, our proposed framework
will be improved by including effects of brain growth and mechan-
ical stimuli (e.g., stress) between the brain and growing bone and
pressure distribution in head.
5. CONCLUSION
Growth of the cranial vault is coordinated through tissue–tissue
interactions between the brain, the developing meninges, the bone
primordia, and the cranial sutures (Han et al., 2007), but the
specifics are not well defined. Here, the processes associated with
formation of primary centers of ossification and bone growth
were mathematically modeled and solved using the finite vol-
ume method. The results show that five primary ossification
centers form at positions like those identified in experimental data
(Figure 10). Our results reveal bone growing from the primary
ossification centers forming sutures between bones (Figure 11).
Our study shows that the development of the cranial vault can be
numerically simulated using the established computational frame-
work. We expect that changes in model parameters, when exam-
ined in parallel with laboratory experimentation, will help clarify
some of the key players and mechanisms of skull development,
both normal and pathological.
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